HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome.

Abstract
Tegaserod is a selective partial agonist acting on serotonergic type 4 receptors (5-HT(4)). Pharmacodynamic studies indicate that tegaserod is able to stimulate gut propulsion and secretion with a net prokinetic effect. In contrast to other 5-HT(4) agonists endowed with a complex pharmacological profile, tegaserod has a reliable prokinetic activity in the colon. Clinical trials show that tegaserod is effective and safe in the treatment of patients with irritable bowel syndrome. In particular, tegaserod relieves symptoms of abdominal pain, discomfort, abdominal bloating and constipation.
AuthorsMaura Corsetti, Jan Tack
JournalExpert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 3 Issue 8 Pg. 1211-8 (Aug 2002) ISSN: 1465-6566 [Print] England
PMID12150698 (Publication Type: Journal Article, Review)
Chemical References
  • Indoles
  • Serotonin Receptor Agonists
  • tegaserod
Topics
  • Animals
  • Biological Availability
  • Clinical Trials as Topic
  • Colonic Diseases, Functional (diagnosis, drug therapy, physiopathology)
  • Drug Interactions
  • Half-Life
  • Humans
  • Indoles (pharmacokinetics, therapeutic use, toxicity)
  • Intestinal Absorption
  • Serotonin Receptor Agonists (pharmacokinetics, therapeutic use, toxicity)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: